Proactive Investors - Run By Investors For Investors

Namaste's agreed-upon medical cannabis vendor Agraflora provides additional information on supply deal

The supplier is meeting a request from the Investment Industry Regulatory Organization of Canada
A marijuana plant
The cannabis deal is subject to approval of Agraflora’s cultivation and sales licenses

Namaste Technologies Inc’s (CVE:N) (OTCMKTS:NXTTF) agreed-upon medical cannabis vendor Agraflora Organics International Inc (CSE AGRA) (OTCMKTS:PUFXF) said it provided additional information on its supply agreement at the request of the Investment Industry Regulatory Organization of Canada.

Under the deal announced Thursday, Toronto-based Namaste’s Cannmart unit has the right of first refusal to purchase up to 10% of the total annual production from Agraflora's Delta, British Columbia, greenhouse complex. That represents 25 million grams, at a price of C$4 per gram, or as much as C$100 million.

READ: Namaste unit may buy up to C$100M of medical cannabis from Agraflora Organics annually

The deal is subject to approval of Agraflora’s cultivation and sales licenses by Health Canada.

When the 2.2-million-square-foot Delta greenhouse complex is fully operational in 2021, it is projected to have an annual capacity of 250 million grams of high-quality cannabis.

Shares of Namaste traded at C$1.23 in Thursday’s Canadian trading. They slipped US$0.04 to US$0.93 on the OTC Markets. Agraflora traded at C$0.22 in Canada and gained US$0.03 to US$0.16 on the OTC Markets.


Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full N profile View Profile

Namaste Technologies Inc Timeline

Related Articles

porcupine
November 30 2018
It’s been a tricky period for Redx, but it has come through it with a promising pipeline, cash in the bank and AstraZeneca’s former UK boss as its new chief executive
man coughing
November 09 2018
Some of the big boys are shifting their focus away from their respiratory drugs, which could open up opportunities for Circassia to in-license them
Medical scanner
February 08 2019
The company’s digital platform and Artificial Intelligence (AI) software manages and helps interpret images from MRI (magnetic resonance imaging) and PRT (positron emission tomography) scanners
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use